Conference item icon

Conference item

Towards the first antibody-free serum biomarker assay for NAFLD

Abstract:
Liver biopsy is the reference standard for NAFLD diagnosis and staging. NAFLD can be assessed less invasively using immunoassays to detect serum biomarkers. However, biomarkers can degrade due to sample storage conditions and therefore may not be detected using these antibody-based assays. Detection of biomarkers by mass spectrometry (MS) overcomes this disadvantage.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.4172/2167-0889-C1-014

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Biochemistry
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Biochemistry
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Biochemistry
Role:
Author
Expand authors...
Publisher:
OMICS International Publisher's website
Volume:
6
Issue:
3
Pages:
32
Publication date:
2017-08-05
DOI:
Pubs id:
pubs:812623
URN:
uri:f222e887-0047-417f-ae4d-623769e15a92
UUID:
uuid:f222e887-0047-417f-ae4d-623769e15a92
Local pid:
pubs:812623

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP